Promising MAC lung drug trial halted midway
Disease control
Terminated
This study tested an oral drug called epetraborole for people with a stubborn lung infection called MAC that did not improve with standard treatments. The trial aimed to see if adding epetraborole to usual care could improve symptoms and clear the infection. However, the study wa…
Phase: PHASE2, PHASE3 • Sponsor: AN2 Therapeutics, Inc • Aim: Disease control
Last updated Jun 16, 2026 12:48 UTC